CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 107 enrolled
Drug / intervention
Hydroxycobalamin (Vitamin B12 Depot, Nycomed Pharma)drug
Likely dose
Hydroxycobalamin (Vitamin B12 Depot, Nycomed Pharma) 400 µgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00479479
NCT00479479N/ACompleted

Cobalamin Supplementation During Infancy; Effect on B-vitamin Status, Growth and Psychomotor Development

Haukeland University Hospital·interventional·Posted May 28, 2007·Updated Jul 21, 2015

In Brief

A clinical study evaluating Hydroxycobalamin (Vitamin B12 Depot, Nycomed Pharma) for Vitamin B 12 Deficiency. Completed, enrolled 107 participants across 1 site.

Detailed Summary

Adequate levels of vitamin B12 (cobalamin) is necessary for normal growth and development in infants. We have earlier investigated cobalamin status in healthy children and we observed metabolic evidence of impaired cobalamin status during the first 6 months, but not later in life. The purpose of this study is to determine if cobalamin supplementation may influence the metabolic profile related to cobalamin status in infants.

Study Details

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 28, 2007
Enrollment StartDec 1, 2004
Primary CompletionAug 1, 2006
Study CompletionDec 1, 2006
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 19.1 years ago

Interventions

Hydroxycobalamin (Vitamin B12 Depot, Nycomed Pharma)drug

an intramuscular injection of 400 µg hydroxycobalamin (Vitamin B12 Depot, Nycomed Pharma, Norway)